skeleton
|
• reduced synovial inflammation in aged tamoxifen-treated mice
|
|
• protected in aged mice treated with tamoxifen with the articular cartilage relatively intact
|
|
• in tamoxifen-treated mice
|
short radius
(
J:365755
)
|
• in tamoxifen-treated mice
|
short ulna
(
J:365755
)
|
• in tamoxifen-treated mice
|
short femur
(
J:365755
)
|
• in tamoxifen-treated mice
|
short tibia
(
J:365755
)
|
• in tamoxifen-treated mice
|
|
• decreased length in first to fifth lumbar spines in tamoxifen-treated mice
|
|
• impaired embryonic chondrocyte senescence in mice treated with tamoxifen
|
growth/size/body
|
• at E13.5, E16.5, and E18.5 in tamoxifen-treated mice exposed to tamoxifen in utero
|
immune system
|
• reduced synovial inflammation in aged tamoxifen-treated mice
|
|
• protected in aged mice treated with tamoxifen with the articular cartilage relatively intact
|
limbs/digits/tail
|
• in tamoxifen-treated mice
|
short radius
(
J:365755
)
|
• in tamoxifen-treated mice
|
short ulna
(
J:365755
)
|
• in tamoxifen-treated mice
|
short femur
(
J:365755
)
|
• in tamoxifen-treated mice
|
short tibia
(
J:365755
)
|
• in tamoxifen-treated mice
|


Analysis Tools